Logo Image
News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement
|Articles|April 17, 2012

Supreme Court to Consider Sales Rep Overtime

Author(s)Reid Paul
Advertisement
Advertisement
Blogs

Related Content

Advertisement
© putilov_denis - © putilov_denis - stock.adobe.com

Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection

ByLauren Crooks, MSc, Greta Marie van Schoor, PhD, Anthony Everhart, MD, Bill Byrom, PhD, and Thijs Sondag
July 31st 2026

How to Prevent Continuous Data Review from Just Shifting the Manual Burden

ByRaviv Pryluk, PhD,Andy Studna, Senior Editor
July 31st 2026

ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access

ByAndy Studna, Senior Editor
July 31st 2026
© Grispb - © Grispb - stock.adobe.com

Artificial Intelligence in Clinical Trials: From Pilots to Practice

ByAndy Studna, Senior Editor
July 30th 2026

What the Industry Needs to Get Right for Real-Time Data Review to Scale

ByRaviv Pryluk, PhD,Andy Studna, Senior Editor
July 30th 2026
Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access

2

Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection

3

ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion

4

FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility

5

ACT Brief: Data Pipeline Standardization for Real-Time Analysis, Sponsor Accountability Beyond Contracts, and Autoimmune Pipeline Expansion

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us